Tag Archives: Enzo Life Sciences

June 2018—Enzo Life Sciences introduced three clinically relevant antibodies for immunohistochemistry detection.

July 2017—Enzo Life Sciences unveiled its Multiview Plus (mouse-HRP/rabbit-AP) IHC Kit (brown/green). This nonbiotin nanopolymer detection system contains reagents and materials that detect and localize antigens in formalin-fixed, paraffin-embedded tissues. The kit optimizes the IHC process by including the entire workflow, from antigen retrieval to visualization.

January 2017—Enzo Life Sciences introduced the PlaqPro Lp-PLA2 assay, a colorimetric readout assay that measures the activity of Lp-PLA2 in serum samples. The assay is designed to run on automated chemistry analyzers. Included in the kit are ready-to-use calibration standards and QC controls in order to measure a wide analytical range of 0.0–400.0 nmol/min/mL of Lp-PLA2 activity.

November 2016—nzo Life Sciences introduced its new line of in situ hybridization and immunohistochemistry reagents for use with Enzo’s Highdef chromogens in ISH and IHC applications.

July 2016—The Cyto-ID Autophagy Detection Kit 2.0 from Enzo Life Sciences measures autophagic vacuoles and monitors autophagic flux in lysosomally inhibited live cells using a novel dye that selectively labels accumulated autophagic vacuoles.

May 2016—Enzo Life Sciences now offers the Cytag TotalCGH Labeling Kit for CGH+SNP arrays. Array-based comparative genomic hybridization is a well-established method for investigating copy number variations and is used to detect a variety of genomic gains and losses from duplications and deletions, unbalanced translocations, and aneuploidies.

April 2016—Enzo Life Sciences now offers Digoxigenin-dUTP and Digoxigenin-UTP, digoxigenin-labeled nucleotides that are suitable for a variety of molecular biology applications.

February 2016—Enzo Life Sciences now offers EQ Quencher Dyes—amine-reactive quencher dyes that can be used for fluorescence resonance energy transfer (FRET) applications.

January 2016—Enzo Life Sciences launched a VEGF ELISA kit that provides a quantitative, competitive detection method for measuring melatonin in serum, plasma, and cell culture supernants.

The Insulin and Proinsulin ELISA kits from Enzo Life Sciences allow for the quantitative determination of insulin and proinsulin in serum and plasma. The kits provide a highly sensitive measurement, detecting as little as 0.622 µIU/mL (insulin) and 0.17 pM (proinsulin), deliver fully quantitative results that surpass semiquantitative Western blot analysis, and can analyze up to 40 samples in duplicate in three hours.

June 2015—Consortium gaining ground in quest for interoperability; Xifin purchases VisualShare; CDC releases update on electronic lab result reporting to public health agencies; Enzo Life Sciences releases ELISA plate reader app; Orchard Software features white papers on website; Imprivata expands reach with acquisition of HT Systems; Sampleminded teams up with Exact Sciences

May 2015—The Methotrexate ELISA kit from Enzo Life Sciences enables the monitoring of methotrexate levels during treatment of cancer and rheumatoid arthritis. The assay is also appropriate for the detection of methotrexate contamination after its use as a selective agent for recombinant protein production in mammalian cell lines.

March 2014—Enzo Life Sciences’ Histamine ELISA kit provides a quantitative detection method for measuring histamine in human, rat, mouse, and canine samples. Because of histamine’s potent role in the immune response, it is present in a transitory state in the body and can only be measured within minutes of release. The half-life of histamine in a biological system is four minutes before its conversion to n-methyl histamine.

January 2015—Enzo Life Sciences introduced an LH ELISA Kit for sensitive and rapid detection of luteinizing hormone.

October 2014—Enzo Life Sciences now offers the Amp’d GLP-1 ELISA Kit, a rapid ELISA for the detection of the active form of glucagon-like peptide 1. The kit can be used to quantify the active form of human GLP-1 in serum and plasma samples.

June 2014—Enzo’s quantitative, high-sensitivity ELISA kit for Alzheimer research enables identification and quantification of APP ∆C31.

May 2014—Enzo Life Sciences now offers the Amp’d HSP70 High Sensitivity ELISA Kit for detecting both baseline and upregulated levels of Hsp70 (Hsp72).

March 2014—Enzo Life Sciences’ high-sensitivity Grp78/BiP ELISA kit is an endoplasmic reticulum-specific homologue of Hsp70, serving as a critical stress-sensing chaperone and regulator of the unfolded protein response (UPR). Grp78 helps fold misfolded proteins, prevent protein aggregation, and regulate protein degradation, synthesis, transportation, and oligomerization.

February 2014—Enzo Life Sciences now offers a KIM-1 ELISA kit. Kidney injury marker 1 (KIM-1) is the most highly upregulated protein in the proximal tubule of the injured kidney and is detectable in the urine within six hours of injury. KIM-1 has been identified as an early diagnostic and prognostic marker of acute kidney injury resulting from illness, trauma, or nephrotoxicity, and with decreased kidney function and renal failure associated with chronic disorders such as diabetes and high blood pressure.

February 2014—Enzo Biochem published a study in Modern Pathology that shows a strong association between idiopathic pulmonary fibrosis (IPF) and the presence of the herpesvirus saimiri virus, a virus native to squirrel monkeys. The breakthrough discovery of the IPF’s origin is expected to result in a clinical diagnostic that could lead to screening and diagnosis, and perhaps result in potential treatment, for this fatal disease.

January 2014—Enzo Life Sciences has expanded its portfolio of drug discovery platforms with the introduction of the new Leading Light Sclerostin-LRP Screening System. Developed to meet the market need for a simple, sensitive biochemical screening assay for detection of sclerostin inhibitors (antagonists of the Wnt signaling pathway), this kit is a drug discovery tool for detecting small molecule inhibitors that disrupt the interaction between SOST and LRP5.

Enzo Life Sciences’ high-efficiency BioArray conversion kits for detecting 5-mC and 5-hmC modifications (Express DNA methylation kit, blood and tissue DNA methylation kit, and BioArray 5-hmC methylation kit) allow for resolution of single-nucleotide changes without introducing DNA damage. Features such as capacity for multiple sample inputs, rapid processing time, and high-conversion efficiency rate provide enhanced flexibility without sacrificing performance.